When should the nurse notify the provider if the patient’s capillary blood glucose is high before initiating basal insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Notify Provider Before Starting Basal Insulin

The nurse should notify the provider immediately if the patient's blood glucose is ≥400 mg/dL (22.2 mmol/L), or if blood glucose is ≥300 mg/dL (16.7 mmol/L) with symptoms of hyperglycemia, before initiating basal insulin. Additionally, notify for blood glucose ≥300 mg/dL (16.7 mmol/L) with signs of ketosis (ketonuria ≥1+ or ketonaemia >0.5 mmol/L), as these patients may require IV insulin infusion instead of subcutaneous basal insulin 1.

Critical Thresholds Requiring Provider Notification

Immediate Notification Required:

  • Blood glucose ≥400 mg/dL (≥22.2 mmol/L): These patients typically need higher initial insulin doses (0.5 U/kg/day total daily dose) and may require more aggressive management 2

  • Blood glucose ≥300 mg/dL (16.7 mmol/L) with symptomatic hyperglycemia: Symptoms include polyuria, polydipsia, weight loss, or altered mental status. These patients may need immediate insulin therapy with consideration for IV insulin if severely symptomatic 3, 4

  • Pre-prandial blood glucose ≥300 mg/dL (16.5 mmol/L) with ketosis present: Check for ketonuria (≥1+) or ketonaemia (>0.5 mmol/L). If ketonaemia is ≥1.5 mmol/L or ketonuria is 2+, the patient requires transfer to ICU for IV insulin infusion therapy rather than subcutaneous basal insulin 1

Standard Protocol for Initiating Basal Insulin

For patients WITHOUT the above critical thresholds, nurses can typically proceed with basal insulin initiation following established protocols, but should still notify the provider for documentation and order verification:

  • Blood glucose 201-400 mg/dL (11.2-22.2 mmol/L): Start with 0.5 U/kg/day total daily dose (50% basal, 50% nutritional) 2

  • Blood glucose 140-200 mg/dL (7.8-11.1 mmol/L): Start with 0.4 U/kg/day total daily dose 2

  • Elderly (≥70 years) or renal impairment (GFR <60 mL/min): Start with lower dose of 0.2-0.3 U/kg/day regardless of blood glucose level 2

Additional Situations Requiring Provider Notification

Persistent Hyperglycemia on Correctional Insulin Alone:

Notify the provider if ≥2 point-of-care blood glucose measurements are ≥180 mg/dL (≥10.0 mmol/L) within a 24-hour period in patients currently on correctional insulin only. These patients need scheduled basal insulin added to their regimen 5.

Confirmed Admission Blood Glucose:

For patients with diabetes treated with diet or noninsulin medications prior to admission, notify the provider if admission blood glucose is ≥180 mg/dL (≥10.0 mmol/L) to initiate scheduled insulin therapy rather than correctional insulin alone 5.

Common Pitfalls to Avoid

  • Do not delay notification for blood glucose ≥400 mg/dL thinking you can manage with sliding scale insulin alone. Sliding scale insulin as sole therapy is strongly discouraged and leads to poor glycemic control 2, 6

  • Do not start basal insulin without checking for ketosis when blood glucose is ≥300 mg/dL. Missing ketosis can lead to inappropriate subcutaneous insulin administration when IV insulin is needed 1

  • Do not use the same starting dose for elderly patients or those with renal impairment. These patients require 30-50% lower starting doses to prevent hypoglycemia 2

  • For patients with type 1 diabetes, never hold basal insulin even if NPO. These patients require continuous basal insulin coverage and provider notification is essential if there's any question about insulin administration 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.